US Stock MarketDetailed Quotes

Mirum Pharmaceuticals (MIRM)

Watchlist
  • 97.950
  • +2.090+2.18%
Close Apr 17 15:59 ET
  • 97.950
  • 0.0000.00%
Post 16:10 ET
5.91BMarket Cap-208.40P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mirum Pharmaceuticals (MIRM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
440.70%55.83M
219.71%6.07M
896.01%39.68M
416.59%12.04M
-112.89%-1.96M
114.55%10.33M
69.50%-5.07M
121.86%3.98M
78.06%-3.8M
181.03%15.21M
Net income from continuing operations
73.43%-23.36M
75.91%-5.73M
120.41%2.91M
76.21%-5.86M
41.94%-14.68M
46.18%-87.94M
33.28%-23.79M
39.65%-14.24M
66.72%-24.64M
16.10%-25.28M
Operating gains losses
-39.72%-1.72M
229.53%193K
-163.85%-643K
-72.39%-612K
62.05%-658K
-169.78%-1.23M
-104.98%-149K
--1.01M
---355K
---1.73M
Depreciation and amortization
2.60%24.24M
0.30%6.07M
0.12%6.06M
3.45%6.06M
6.85%6.05M
118.20%23.63M
10.23%6.06M
127.46%6.06M
338.17%5.85M
323.64%5.66M
Deferred tax
----
----
----
----
----
--0
----
----
----
----
Other non cash items
-6.85%2.07M
23.13%511K
45.72%545K
9.22%545K
-49.89%467K
-95.95%2.22M
-19.26%415K
1.91%374K
-99.00%499K
-77.21%932K
Change In working capital
-187.27%-19.72M
-732.76%-14.01M
1,085.80%12.15M
-519.45%-6.56M
-147.18%-11.3M
217.53%22.59M
77.41%-1.68M
78.17%-1.23M
144.66%1.56M
1,010.00%23.94M
-Change in receivables
-320.58%-48.06M
-74.96%-19.01M
61.16%-3.15M
-66.97%-9.07M
-229.79%-16.83M
74.02%-11.43M
46.04%-10.86M
35.24%-8.1M
49.08%-5.43M
2,044.38%12.97M
-Change in inventory
-166.84%-8.45M
-966.36%-2.28M
-28.35%-1.16M
-115.21%-2.34M
-177.18%-2.67M
-225.05%-3.17M
-117.37%-214K
-105.69%-903K
-9.71%-1.09M
-23.91%-964K
-Change in prepaid assets
-577.97%-5.76M
2,094.14%5.99M
-33.60%-4.63M
-386.26%-4.09M
-429.96%-3.03M
76.42%-849K
278.43%273K
-30.09%-3.47M
292.32%1.43M
2,395.00%918K
-Change in payables and accrued expense
24.29%50.1M
-63.13%3.44M
90.92%24.35M
52.32%10.58M
4.08%11.74M
30.98%40.31M
-25.45%9.34M
23.97%12.75M
-24.32%6.94M
1,030.45%11.28M
-Change in other current assets
-278.04%-5.66M
-81,750.00%-1.64M
-90.63%-2.68M
-1,162.63%-1.25M
-936.36%-92K
-193.15%-1.5M
99.71%-2K
-2,773.47%-1.41M
-76.79%-99K
-96.14%11K
-Change in other current liabilities
-142.46%-1.9M
-139.72%-513K
-447.17%-580K
-104.66%-395K
-51.67%-408K
16.81%-782K
6.55%-214K
60.45%-106K
13.84%-193K
-22.83%-269K
Cash from discontinued investing activities
Operating cash flow
440.70%55.83M
219.71%6.07M
896.01%39.68M
416.59%12.04M
-112.89%-1.96M
114.55%10.33M
69.50%-5.07M
121.86%3.98M
78.06%-3.8M
181.03%15.21M
Investing cash flow
Cash flow from continuing investing activities
73.42%-23.95M
56.94%1.01M
87.65%-2.23M
90.93%-6.6M
-124,007.69%-16.13M
15.93%-90.13M
132.05%641K
90.13%-18.04M
-243.86%-72.72M
-100.05%-13K
Net PPE purchase and sale
3.93%-954K
-2,900.00%-600K
-3.31%-187K
83.83%-126K
-215.38%-41K
-811.01%-993K
---20K
---181K
-1,045.59%-779K
68.29%-13K
Net intangibles purchase and sale
--0
--0
--0
----
----
0.00%-20M
--0
---10M
---10M
--0
Net business purchase and sale
--0
----
----
----
----
--0
--0
----
----
----
Net investment purchase and sale
66.73%-23M
142.97%1.61M
74.03%-2.04M
89.55%-6.47M
---16.09M
-155.01%-69.13M
-77.97%661K
-126.18%-7.86M
-222.37%-61.94M
--0
Cash from discontinued investing activities
Investing cash flow
73.42%-23.95M
56.94%1.01M
87.65%-2.23M
90.93%-6.6M
-124,007.69%-16.13M
15.93%-90.13M
132.05%641K
90.13%-18.04M
-243.86%-72.72M
-100.05%-13K
Financing cash flow
Cash flow from continuing financing activities
126.80%40.14M
68.52%9M
316.67%16.1M
19.16%8.69M
427.72%6.36M
-94.74%17.7M
200.51%5.34M
-98.13%3.86M
-93.64%7.29M
-90.72%1.21M
Net issuance payments of debt
--0
----
----
----
----
--0
--0
--0
----
----
Net common stock issuance
--0
----
----
----
----
--0
--0
--0
--0
--0
Cash dividends paid
----
----
----
----
----
----
----
----
----
--0
Proceeds from stock option exercised by employees
126.80%40.14M
68.52%9M
316.67%16.1M
19.16%8.69M
427.72%6.36M
69.04%17.7M
140.87%5.34M
-18.95%3.86M
247.69%7.29M
-13.31%1.21M
Cash from discontinued financing activities
Financing cash flow
126.80%40.14M
68.52%9M
316.67%16.1M
19.16%8.69M
427.72%6.36M
-94.74%17.7M
200.51%5.34M
-98.13%3.86M
-93.64%7.29M
-90.72%1.21M
Net cash flow
Beginning cash position
-22.14%222.93M
26.46%282.5M
-2.10%228.6M
-29.92%212.25M
-22.14%222.93M
123.69%286.33M
-26.29%223.39M
-21.44%233.5M
102.68%302.84M
123.69%286.33M
Current changes in cash
215.96%72.02M
1,660.35%16.07M
625.57%53.55M
120.41%14.13M
-171.54%-11.74M
-139.19%-62.1M
105.42%913K
-265.78%-10.19M
-146.80%-69.23M
-22.72%16.4M
Effect of exchange rate changes
348.42%3.22M
70.41%-408K
296.59%349K
1,970.59%2.23M
833.63%1.06M
-875.19%-1.3M
-1,376.85%-1.38M
127.94%88K
-4.39%-119K
-39.89%113K
End cash Position
33.75%298.17M
33.75%298.17M
26.46%282.5M
-2.10%228.6M
-29.92%212.25M
-22.14%222.93M
-22.14%222.93M
-26.29%223.39M
-21.44%233.5M
102.68%302.84M
Free cash flow
614.37%54.87M
207.45%5.47M
737.31%39.49M
181.70%11.91M
-113.17%-2M
88.28%-10.67M
76.46%-5.09M
65.99%-6.2M
16.19%-14.58M
144.95%15.2M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 440.70%55.83M219.71%6.07M896.01%39.68M416.59%12.04M-112.89%-1.96M114.55%10.33M69.50%-5.07M121.86%3.98M78.06%-3.8M181.03%15.21M
Net income from continuing operations 73.43%-23.36M75.91%-5.73M120.41%2.91M76.21%-5.86M41.94%-14.68M46.18%-87.94M33.28%-23.79M39.65%-14.24M66.72%-24.64M16.10%-25.28M
Operating gains losses -39.72%-1.72M229.53%193K-163.85%-643K-72.39%-612K62.05%-658K-169.78%-1.23M-104.98%-149K--1.01M---355K---1.73M
Depreciation and amortization 2.60%24.24M0.30%6.07M0.12%6.06M3.45%6.06M6.85%6.05M118.20%23.63M10.23%6.06M127.46%6.06M338.17%5.85M323.64%5.66M
Deferred tax ----------------------0----------------
Other non cash items -6.85%2.07M23.13%511K45.72%545K9.22%545K-49.89%467K-95.95%2.22M-19.26%415K1.91%374K-99.00%499K-77.21%932K
Change In working capital -187.27%-19.72M-732.76%-14.01M1,085.80%12.15M-519.45%-6.56M-147.18%-11.3M217.53%22.59M77.41%-1.68M78.17%-1.23M144.66%1.56M1,010.00%23.94M
-Change in receivables -320.58%-48.06M-74.96%-19.01M61.16%-3.15M-66.97%-9.07M-229.79%-16.83M74.02%-11.43M46.04%-10.86M35.24%-8.1M49.08%-5.43M2,044.38%12.97M
-Change in inventory -166.84%-8.45M-966.36%-2.28M-28.35%-1.16M-115.21%-2.34M-177.18%-2.67M-225.05%-3.17M-117.37%-214K-105.69%-903K-9.71%-1.09M-23.91%-964K
-Change in prepaid assets -577.97%-5.76M2,094.14%5.99M-33.60%-4.63M-386.26%-4.09M-429.96%-3.03M76.42%-849K278.43%273K-30.09%-3.47M292.32%1.43M2,395.00%918K
-Change in payables and accrued expense 24.29%50.1M-63.13%3.44M90.92%24.35M52.32%10.58M4.08%11.74M30.98%40.31M-25.45%9.34M23.97%12.75M-24.32%6.94M1,030.45%11.28M
-Change in other current assets -278.04%-5.66M-81,750.00%-1.64M-90.63%-2.68M-1,162.63%-1.25M-936.36%-92K-193.15%-1.5M99.71%-2K-2,773.47%-1.41M-76.79%-99K-96.14%11K
-Change in other current liabilities -142.46%-1.9M-139.72%-513K-447.17%-580K-104.66%-395K-51.67%-408K16.81%-782K6.55%-214K60.45%-106K13.84%-193K-22.83%-269K
Cash from discontinued investing activities
Operating cash flow 440.70%55.83M219.71%6.07M896.01%39.68M416.59%12.04M-112.89%-1.96M114.55%10.33M69.50%-5.07M121.86%3.98M78.06%-3.8M181.03%15.21M
Investing cash flow
Cash flow from continuing investing activities 73.42%-23.95M56.94%1.01M87.65%-2.23M90.93%-6.6M-124,007.69%-16.13M15.93%-90.13M132.05%641K90.13%-18.04M-243.86%-72.72M-100.05%-13K
Net PPE purchase and sale 3.93%-954K-2,900.00%-600K-3.31%-187K83.83%-126K-215.38%-41K-811.01%-993K---20K---181K-1,045.59%-779K68.29%-13K
Net intangibles purchase and sale --0--0--0--------0.00%-20M--0---10M---10M--0
Net business purchase and sale --0------------------0--0------------
Net investment purchase and sale 66.73%-23M142.97%1.61M74.03%-2.04M89.55%-6.47M---16.09M-155.01%-69.13M-77.97%661K-126.18%-7.86M-222.37%-61.94M--0
Cash from discontinued investing activities
Investing cash flow 73.42%-23.95M56.94%1.01M87.65%-2.23M90.93%-6.6M-124,007.69%-16.13M15.93%-90.13M132.05%641K90.13%-18.04M-243.86%-72.72M-100.05%-13K
Financing cash flow
Cash flow from continuing financing activities 126.80%40.14M68.52%9M316.67%16.1M19.16%8.69M427.72%6.36M-94.74%17.7M200.51%5.34M-98.13%3.86M-93.64%7.29M-90.72%1.21M
Net issuance payments of debt --0------------------0--0--0--------
Net common stock issuance --0------------------0--0--0--0--0
Cash dividends paid --------------------------------------0
Proceeds from stock option exercised by employees 126.80%40.14M68.52%9M316.67%16.1M19.16%8.69M427.72%6.36M69.04%17.7M140.87%5.34M-18.95%3.86M247.69%7.29M-13.31%1.21M
Cash from discontinued financing activities
Financing cash flow 126.80%40.14M68.52%9M316.67%16.1M19.16%8.69M427.72%6.36M-94.74%17.7M200.51%5.34M-98.13%3.86M-93.64%7.29M-90.72%1.21M
Net cash flow
Beginning cash position -22.14%222.93M26.46%282.5M-2.10%228.6M-29.92%212.25M-22.14%222.93M123.69%286.33M-26.29%223.39M-21.44%233.5M102.68%302.84M123.69%286.33M
Current changes in cash 215.96%72.02M1,660.35%16.07M625.57%53.55M120.41%14.13M-171.54%-11.74M-139.19%-62.1M105.42%913K-265.78%-10.19M-146.80%-69.23M-22.72%16.4M
Effect of exchange rate changes 348.42%3.22M70.41%-408K296.59%349K1,970.59%2.23M833.63%1.06M-875.19%-1.3M-1,376.85%-1.38M127.94%88K-4.39%-119K-39.89%113K
End cash Position 33.75%298.17M33.75%298.17M26.46%282.5M-2.10%228.6M-29.92%212.25M-22.14%222.93M-22.14%222.93M-26.29%223.39M-21.44%233.5M102.68%302.84M
Free cash flow 614.37%54.87M207.45%5.47M737.31%39.49M181.70%11.91M-113.17%-2M88.28%-10.67M76.46%-5.09M65.99%-6.2M16.19%-14.58M144.95%15.2M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -